Cover 2 Resources
Cover 2 Resources
Ep. 177 - Expanding Naloxone Availability Throughout Our Country to Save Lives
Ep. 177 - Expanding Naloxone Availability Throughout Our Country to Save Lives
Ep. 177 - Expanding Naloxone Availability Throughout Our Country to Save Lives
Tuesday 17th April 2018
Matt Ruth of Adapt Pharma talks about expanding access to NARCAN Nasal Spray and its role in reversing opioid overdoses on Cover 2 Resources.
29 minutes
Informative
Empowering
Hopeful
Educational
Supportive
About this podcast
Overview:
Categories:
Innovative Treatments & Recovery Paths
Family Recovery from Addiction
Sobriety Toolkit
Body & Mind
Navigating Intimate Relationships
Links:
Visit site
Episodes:
284 (View all)
Do you want to link to this podcast?
Get the buttons here!Saving Lives with Naloxone: Matt Ruth's Mission at Adapt Pharma
We believe that all law enforcement should carry naloxone, first and foremost to protect, you know, the citizens and folks within their communities and second, to protect themselves against the potential of coming across fentanyl themselves.
Imagine a world where a simple nasal spray can save lives in the midst of an opioid crisis. In this episode of the Cover 2 Resources podcast, host Greg McNeil sits down with Matt Ruth, Chief Commercial Officer at Adapt Pharma, to discuss their commitment to making NARCAN Nasal Spray more accessible and affordable. NARCAN, a brand name for Naloxone, is a critical tool used by first responders to reverse opioid overdoses.
But it’s not just about the product; it’s about breaking down the stigma and ensuring that those who need it can get it without financial barriers. Matt Ruth shares the challenges and triumphs of keeping Naloxone affordable despite market pressures to hike prices. He explains how Adapt Pharma has maintained consistent pricing since the beginning and continues to advocate for broader awareness and availability.
The conversation also touches on the essential role of law enforcement in carrying Naloxone, not only to save lives but also to protect themselves from accidental exposure to substances like Fentanyl. One of the most compelling points Matt makes is that while Naloxone isn’t a treatment for addiction, it serves as a crucial bridge to get individuals into recovery programs.
“Naloxone is not a solution for treatment, but hopefully a bridge to treatment”, he says, highlighting the window of opportunity that opens when someone is revived from an overdose. This episode is a must-listen for anyone affected by the opioid crisis, whether directly or through a loved one. It offers practical insights and hope, showing that with the right tools and support, lives can be saved and futures can be changed.
Tune in to hear how Adapt Pharma is making a difference and learn what you can do to support this vital cause.